Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.lasalabs.com | |
Market Cap | 125.40 Cr. | |
Enterprise Value(EV) | 124.69 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -4.28 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.01 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 22.33 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 1.12 | Calculated using Price: 25.03 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 5.01 Cr. | 50,101,239 Shares |
FaceValue | 10 | |
About Lasa Supergenerics Ltd. | ||
The company is specialises in ‘catalyst chemistry' and manufactures anthelmintic/ veterinary API products with the largest production capabilities and product categories in India |
1 Day |
|
-1.36% |
1 Week |
|
-0.12% |
1 Month |
|
+6.67% |
3 Month |
|
-21.59% |
6 Month |
|
-5.01% |
1 Year |
|
+11.15% |
2 Year |
|
-56.47% |
5 Year |
|
+6.58% |
10 Year |
|
8 years | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 0 | 8.65 | 14.33 | -10.81 | 2.94 | 15.17 | -3.37 | -27.97 | |
Return on Capital Employed (%) | 0 | 14.45 | 12.8 | -3.73 | 6.77 | 17.14 | -3.41 | -23.94 | |
Return on Assets (%) | 0 | 2.07 | 4.79 | -4.44 | 1.5 | 10.43 | -2.56 | -20.71 |
Particulars | 9 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 0 | 75 | 117 | 105 | 141 | 159 | 158 | 118 | 113 | |
Non Curr. Liab. | 0 | 83 | 62 | 43 | 11 | 8 | 7 | 3 | 7 | |
Curr. Liab. | 70 | 107 | 107 | 76 | 41 | 45 | 43 | 46 | ||
Minority Int. | ||||||||||
Equity & Liab. | 0 | 228 | 287 | 255 | 229 | 208 | 209 | 164 | 166 | |
Non Curr. Assets | 149 | 178 | 170 | 153 | 144 | 143 | 125 | 120 | ||
Curr. Assets | 0 | 79 | 109 | 86 | 76 | 64 | 66 | 39 | 45 | |
Misc. Exp. not W/O | 0 | |||||||||
Total Assets | 0 | 228 | 287 | 255 | 229 | 208 | 209 | 164 | 166 |
Particulars | 9 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 199 | 244 | 170 | 167 | 202 | 137 | 130 | 117 | ||
Other Income | 2 | 3 | 1 | 0 | 0 | 0 | 2 | 1 | ||
Total Income | 201 | 247 | 170 | 167 | 203 | 137 | 131 | 118 | ||
Total Expenditure | -153 | -202 | -159 | -137 | -155 | -121 | -136 | -106 | ||
PBIDT | 48 | 45 | 12 | 30 | 47 | 16 | -5 | 12 | ||
Interest | -12 | -11 | -8 | -8 | -2 | 0 | -4 | -2 | ||
Depreciation | -8 | -18 | -19 | -17 | -16 | -15 | -13 | -12 | ||
Taxation | 0 | -3 | 4 | -1 | -7 | 1 | 4 | 1 | ||
Exceptional Items | -26 | -8 | -20 | -20 | ||||||
PAT | 2 | 12 | -12 | 4 | 23 | -5 | -39 | -21 | ||
Adjusted EPS | 472 | 5 | -5 | 1 | 6 | -1 | -8 | -4 |
Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | -3 | 40 | 41 | 14 | 41 | 9 | -17 | |
Cash Fr. Inv. | 0 | -44 | -7 | -2 | -4 | -3 | 11 | ||
Cash Fr. Finan. | 0 | 0 | 4 | -33 | -10 | -36 | 0 | -4 | |
Net Change | 0 | -3 | 0 | 0 | 2 | 1 | 6 | -10 | |
Cash & Cash Eqvt | 0 | 0 | 1 | 0 | 3 | 4 | 11 | 1 |
Mon, 15 Apr 2024
Compliance Under Reg 7(3) SEBI LODR Regulations 2015 For The Period Ended March 31 2024 Pursuant to Regulation 7 (3) of SEBI LODR Regulations 2015 We hereby confirm that all activities in relation to both physical and electronic share transfer facility during period 1st April 2023 to 31st March 2024 (both days inclusive) are maintained by our Registrar and Share Transfer Agent - BigShare Services Private Limited having permanant SEBI Registration No. INR000001385 |
Mon, 15 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under regulation 74 (5) SEBI (Depositories and Participants) Regulations 2018 for the quarter and the year ended March 31 2024 received from Bigshare Services Private Limited Registrar and Share Transfer Agent of the Company. |
Fri, 29 Mar 2024
Closure of Trading Window This is to Inform you that as per the company code of Conduct for Regulation Monitoring and Reporting of Trading by Insiders in terms of ( Prohibition of Insider Trading) Regulations 2015 as amended the Trading window for dealing of Equity Share of the Company has been closed for designated employee and their immediate relatives w.e.f 1st April 2024 to till the 48 hours after the declaration of Audited Financial result (both days inclusive) for the quarter and the year ended March 31 2024 |
Thu, 18 Apr 2024 |
High Delivery Percentage |
Higher Delivery Quantity |
Higher Delivery Quantity and Percentage |
Higher Trade Quantity |
Higher Trade and Delivery Quantity |